🇺🇸 FDA
Patent

US 8338457

Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

granted A61KA61K31/16A61K31/165

Quick answer

US patent 8338457 (Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist) held by The United States of America as represented by the Secretary of the Department of Human Services expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Human Services
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/16, A61K31/165, A61K31/167, A61K31/357